Armistice Capital »

PerkinElmer shares owned by Armistice Capital

Quarter-by-quarter ownership of PerkinElmer (RVTY) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in PerkinElmer

Tip: Access up to 7 years of quarterly data

All positions including PerkinElmer held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in PerkinElmer by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.9M 75k 105.00

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding PerkinElmer

T. Rowe Price Investment Management
Vanguard Group
BlackRock
Select Equity
Henderson Group
Morgan Stanley
Geode Capital Management
Mitsubishi UFJ Asset Management
Pictet Asset Management Holding SA
Millennium Management
Northern Trust
Dimensional Fund Advisors
Ceredex Value Advisors
PRIMECAP Management Company
Massachusetts Financial Services

View all funds holding PerkinElmer